abstract |
The present invention relates to a compound of the general formula (I) wherein R 1 is a group (A) or (B) or (C) or (D); R 2 is a non-aromatic heterocycle, or OR ′ or N (R ″) 2 ; R ′ is lower alkyl, lower alkyl substituted by halogen, or — (CH 2 ) n -cycloalkyl; R ″ is lower alkyl; R 3 is NO 2 , CN or SO 2 R ′; R 4 is hydrogen, hydroxy, halogen, NO 2 , lower alkyl, lower alkyl substituted by halogen, lower alkoxy, SO 2 R ′ or C (O) OR ″; R 5 / R 6 / R 7 is hydrogen, halogen, lower alkyl, or lower alkyl substituted by halogen; X 1 / X 1 ′ is CH or N , however, X 1 / X 1 'at the same time C Rather; X 2 is, O, S, NH, or be N (lower alkyl); n is 0, 1, or a compound of 2 which is]; and pharmaceutically active acid addition salts, as well as neurological Relates to their use in the treatment of psychological and neuropsychiatric disorders. |